Ascendis Pharma A/S
ASND
$191.08
-$4.90-2.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 109.32% | 62.03% | 31.21% | 44.73% | -41.10% |
| Total Receivables | 64.67% | 12.04% | 197.99% | 6.05% | 121.82% |
| Inventory | 32.38% | 26.19% | 32.52% | 47.89% | 46.82% |
| Prepaid Expenses | 2.35% | -20.63% | -31.37% | -10.81% | -16.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 66.50% | 39.01% | 41.40% | 40.00% | -9.15% |
|
|
|||||
| Total Current Assets | 66.50% | 39.01% | 41.40% | 40.00% | -9.15% |
| Net Property, Plant & Equipment | -1.45% | -13.57% | -16.43% | -18.14% | -18.55% |
| Long-term Investments | -- | -- | -6.34% | -- | -- |
| Goodwill | -- | -- | -6.34% | -- | -- |
| Total Other Intangibles | -0.76% | -8.95% | -45.97% | -3.74% | -10.80% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.93% | 25.03% | 2.03% | 8.33% | 3.84% |
| Total Assets | 57.25% | 32.51% | 33.82% | 31.99% | -9.66% |
|
|
|||||
| Total Accounts Payable | 3.21% | -10.58% | -4.53% | -34.75% | -20.01% |
| Total Accrued Expenses | 65.69% | 68.00% | 54.58% | 32.24% | 13.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.72% | 11.71% | 9.29% | 1,704.88% | 1,575.87% |
| Total Finance Division Other Current Liabilities | 38.54% | 12.90% | 31.48% | 813.41% | 1,169.84% |
| Total Other Current Liabilities | 38.54% | 12.90% | 31.48% | 813.41% | 1,169.84% |
| Total Current Liabilities | 20.89% | 11.03% | 15.46% | 315.28% | 332.73% |
|
|
|||||
| Total Current Liabilities | 20.89% | 11.03% | 15.46% | 315.28% | 332.73% |
| Long-Term Debt | 102.23% | 90.23% | 94.62% | -49.46% | -65.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.26% | -4.56% | -14.16% | -11.84% | -10.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.82% | -30.16% | -2.53% | -84.67% | -85.79% |
| Total Liabilities | 29.51% | 20.45% | 23.94% | 32.59% | 39.58% |
|
|
|||||
| Common Stock & APIC | 26.22% | 14.81% | 7.80% | 21.24% | -0.48% |
| Retained Earnings | -18.12% | -11.36% | -5.29% | -21.78% | -17.92% |
| Treasury Stock & Other | -63.15% | 144.90% | 172.03% | -57.51% | -55.44% |
| Total Common Equity | 35.98% | 20.16% | 32.04% | -39.65% | -586.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 35.98% | 20.16% | 32.04% | -39.65% | -586.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 35.98% | 20.16% | 32.04% | -39.65% | -586.08% |
|
|
|||||